Trials / Completed
CompletedNCT01288274
Community Based Distribution of Injectable Contraceptives in Tigray, Ethiopia
Safety and Feasibility of Community Based DMPA Provision in Tigray, Ethiopia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,062 (actual)
- Sponsor
- University of California, Berkeley · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study was to demonstrate that with appropriate training, the provision of injectable contraceptives by community based reproductive health agents (CBRHAs) does not significantly differ from low-level clinic-based providers, or health extension workers (HEWs).
Detailed description
The overall goal of this project was to increase contraceptive prevalence and reduce the current high unmet need for family planning in rural areas of Ethiopia. In addition, the project was intended to provide evidence to policy makers to expand community based distribution (CBD) of the injectible contraceptive, depot medroxyprogesterone acetate (DMPA), in both Tigray and other regions of Ethiopia where community based reproductive health agents (CBRHAs) or other community health workers (CHWs) are present. Following from that, the specific aims of this project were to: * Provide evidence that CBRHAs can safely and effectively distribute and facilitate supply of DMPA to rural women * Demonstrate that CBRHAs can deliver DMPA with the same safety, effectiveness, and acceptability outcomes as HEWs * Increase access to DMPA by using CBRHAs
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Community Based administration of DMPA | Injectable contraceptive administered by clinic based health extension worker or community based reproductive health agent using same protocol to test equivalence of community based distribution to facility based distribution |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2009-08-01
- Completion
- 2009-08-01
- First posted
- 2011-02-02
- Last updated
- 2024-02-15
Locations
3 sites across 1 country: Ethiopia
Source: ClinicalTrials.gov record NCT01288274. Inclusion in this directory is not an endorsement.